person

Sebastien A.

Country
Belgium
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
89
Sites with multiple studies

Has run more than one trial at 89 of 168 partner sites.

Specializations

Multiple Myeloma Research

The investigator specializes in treating multiple myeloma, with particular emphasis on relapsed and refractory cases. Their research encompasses innovative therapeutic approaches including CAR T-cell therapies and novel drug combinations.

  • Newly diagnosed multiple myeloma treatment protocols
  • Advanced therapy medicinal products
  • Combination therapy approaches

A significant focus is placed on developing treatment strategies for patients who have exhausted standard therapeutic options.

Lymphoma Studies

The investigator conducts research in B-cell non-Hodgkin lymphoma and related conditions. Their work includes evaluation of novel therapeutic agents and investigation of immunotherapy approaches.

  • Relapsed/refractory B-cell lymphoma treatments
  • Novel therapeutic agents
  • Long-term patient outcomes

The research extends to innovative treatment approaches for resistant forms of lymphoma.

Leukemia Treatment

Research activities include investigating treatments for acute myeloid leukemia and chronic lymphocytic leukemia. The investigator explores novel drug combinations and targeted therapies.

  • Venetoclax-based combinations
  • Refractory disease management
  • Innovative therapy approaches

Special attention is given to developing treatments for patients with limited therapeutic options.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.